Treatment for Glaucoma

Phase-Based Progress Estimates
All Sexes
What conditions do you have?

Study Summary

This trial will test a new procedure to lower eye pressure in people with early to moderate stage primary open-angle glaucoma who are also having cataract surgery.

Eligible Conditions
  • Glaucoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 24 Month

24 Month
Mean Change in medication-free DIOP from baseline
Proportion of subjects who achieve a decrease in medication-free mean diurnal IOP (DIOP) from baseline of at least 20%

Trial Safety

Trial Design

0 Treatment Group

318 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 month

Who is running the clinical trial?

Elios Vision, Inc.Lead Sponsor
ELT Sight, IncLead Sponsor
Iqbal (Ike) Ahmed, MDStudy DirectorPrism Eye Institute

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
IOP of 22 to 34 mmHg.
You have a diagnosis of mild to moderate POAG.
You have a cataract and a BCVA of 20/40 or worse.

Who else is applying?

What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%